Prevention of cardiovascular ischemic events - High-risk and secondary prevention

被引：30

作者：

Genest, J

Pedersen, TR

机构：

[1] McGill Univ, Ctr Hlth, Div Cardiol, Montreal, PQ, Canada

[2] Aker Hosp, Oslo, Norway

来源：

CIRCULATION | 2003年 / 107卷 / 15期

关键词：

atherosclerosis; prevention; lipoproteins; cholesterol;

D O I：

10.1161/01.CIR.0000067881.26274.BD

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2059 / 2065

页数：7

共 50 条

[1]

Aikawa M, 2001, CIRCULATION, V103, P276

[2]

ANDES PA, 2001, NEW ENGL J MED, V345, P892

[3] Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study [J].

Assmann, G ;

Cullen, P ;

Schulte, H .

CIRCULATION, 2002, 105 (03) :310-315

[4]

Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71

[5] BENEFICIAL-EFFECTS OF COMBINED COLESTIPOL-NIACIN THERAPY ON CORONARY ATHEROSCLEROSIS AND CORONARY VENOUS BYPASS GRAFTS [J].

BLANKENHORN, DH ;

NESSIM, SA ;

JOHNSON, RL ;

SANMARCO, ME ;

AZEN, SP ;

CASHINHEMPHILL, L .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (23) :3233-3240

[6] HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells [J].

Bourcier, T ;

Libby, P .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (02) :556-562

[7] Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease [J].

Brown, BG ;

Zhao, XQ ;

Chait, A ;

Fisher, LD ;

Cheung, MC ;

Morse, JS ;

Dowdy, AA ;

Marino, EK ;

Bolson, EL ;

Alaupovic, P ;

Frohlich, J ;

Albers, JJ ;

Serafini, L ;

Huss-Frechette, E ;

Wang, S ;

DeAngelis, D ;

Dodek, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (22) :1583-1592

[8] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[9]

Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3

[10] Effects of lipid-lowering by simvastatin on human atherosclerotic lesions - A longitudinal study by high-resolution, noninvasive magnetic resonance imaging [J].

Corti, R ;

Fayad, ZA ;

Fuster, V ;

Worthley, SG ;

Helft, G ;

Chesebro, J ;

Mercuri, M ;

Badimon, JJ .

CIRCULATION, 2001, 104 (03) :249-252

← 1 2 3 4 5 →